Sanofi ADR [SNY] stock prices are up 0.67% to $46.24 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The SNY shares have lost -1.93% over the last week, with a monthly amount drifted -3.85%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Sanofi ADR [NASDAQ: SNY] stock has seen the most recent analyst activity on January 23, 2024, when Morgan Stanley initiated its Equal-Weight rating and assigned the stock a price target of $55. On December 05, 2023, downgrade downgraded it’s rating to Neutral. Stifel downgraded its rating to a Hold. Berenberg upgraded its rating to a Buy. In a note dated April 28, 2023, Deutsche Bank downgraded an Sell rating on this stock.
The stock price of Sanofi ADR [SNY] has been fluctuating between $42.63 and $57.82 over the past year. Currently, Wall Street analysts expect the stock to reach $51.54 within the next 12 months. Sanofi ADR [NASDAQ: SNY] shares were valued at $46.24 at the most recent close of the market. An investor can expect a potential return of 11.46% based on the average SNY price forecast.
Analyzing the SNY fundamentals
The Sanofi ADR [NASDAQ:SNY] reported sales of 46.56B for trailing twelve months, representing a drop of -13.36%. Gross Profit Margin for this corporation currently stands at 0.66% with Operating Profit Margin at 0.22%, Pretax Profit Margin comes in at 0.18%, and Net Profit Margin reading is 0.14%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.11 and Total Capital is 0.12. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.23.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 45.87 points at the first support level, and at 45.49 for the second support level. However, for the 1st resistance point, the stock is sitting at 46.76, and for the 2nd resistance point, it is at 47.27.
Ratios To Look Out For
It’s worth pointing out that Sanofi ADR [NASDAQ:SNY]’s Current Ratio is 1.27. Further, the Quick Ratio stands at 0.87, while the Cash Ratio is 0.36. Considering the valuation of this stock, the price to sales ratio is 2.49, the price to book ratio is 1.41 and price to earnings (TTM) ratio is 19.91.
